A detailed history of Morgan Stanley transactions in Global X Fds Genomics & Biotec stock. As of the latest transaction made, Morgan Stanley holds 13,568 shares of GNOM stock, worth $140,021. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,568
Previous 12,563 8.0%
Holding current value
$140,021
Previous $145,000 6.21%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$10.75 - $12.29 $10,803 - $12,351
1,005 Added 8.0%
13,568 $154,000
Q3 2023

Nov 15, 2023

SELL
$10.07 - $12.5 $3,021 - $3,750
-300 Reduced 2.33%
12,563 $127,000
Q2 2023

Aug 14, 2023

SELL
$11.99 - $13.07 $11,354 - $12,377
-947 Reduced 6.86%
12,863 $155,000
Q1 2023

May 15, 2023

BUY
$11.73 - $14.18 $116,936 - $141,360
9,969 Added 259.54%
13,810 $170,000
Q4 2022

Feb 14, 2023

SELL
$12.11 - $13.81 $94,312 - $107,552
-7,788 Reduced 66.97%
3,841 $48,000
Q3 2022

Nov 14, 2022

BUY
$12.23 - $16.28 $2,213 - $2,946
181 Added 1.58%
11,629 $146,000
Q1 2022

May 13, 2022

SELL
$13.33 - $19.98 $4,332 - $6,493
-325 Reduced 2.76%
11,448 $172,000
Q4 2021

Feb 14, 2022

SELL
$19.42 - $22.42 $8,544 - $9,864
-440 Reduced 3.6%
11,773 $234,000
Q3 2021

Nov 15, 2021

BUY
$21.89 - $25.16 $267,342 - $307,279
12,213 New
12,213 $271,000

Others Institutions Holding GNOM

About GLOBAL X FDS GENOMICS & BIOTEC


  • Ticker GNOM
  • Sector ETFs
  • Industry ETFs
More about GNOM
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.